Table 1.
Baseline characteristic | Per/Ind/Aml (n = 75) | Per/Ind + Aml (n = 73) | Global (n = 148) |
---|---|---|---|
Age (years) | 57.2 ± 10.6 | 55.6 ± 10.9 | 56.4 ± 10.8 |
Over 60 years (%) | 46.7 | 41.1 | 43.9 |
Women (%) | 53.3 | 52.1 | 52.7 |
BMI (kg/m2) | 27.8 ± 3.3 | 27.9 ± 2.9 | 27.8 ± 3.1 |
Duration of hypertension (months) | 103.5 ± 89.7 | 94.1 ± 78.7 | 98.9 ± 84.3 |
Family history of hypertension (%) | 68.0 | 72.6 | 70.3 |
Dyslipidemia (%) | 53.3 | 43.8 | 48.7 |
Smoker (%) | 18.7 | 17.8 | 18.2 |
Alcohol consumption (%) | 26.7 | 20.6 | 23.7 |
Previous treatment for hypertension (%) | |||
Monotherapy (%) | 31.1 | 24.3 | 27.8 |
Bi-therapy (%) | 68.9 | 75.7 | 72.2 |
Agents involved (%) | |||
ACEI or ARB | 93.3 | 98.6 | 95.9 |
Diuretic | 61.3 | 68.5 | 64.9 |
CCB | 14.7 | 9.6 | 12.2 |
Concomitant treatment | |||
Lipid modifying agents | 32.0 | 26.0 | 29.1 |
Antithrombotic agents | 22.7 | 21.9 | 22.3 |